ORAL ALTERATIONS IN PATIENTS WITH SJÖGREN´S SYNDROME
Keywords:
Sjogren´s Syndrome, Immune complex diseases, Xerostomia, Dental caries susceptibility, Salivary glands, SalivaAbstract
Sjogren´s Syndrome (SS) is an autoimmune disease, in which the immune system compromises the exocrine glands, involving mainly the salivary and lachrymal glands. Xerostomia is the most evident oral symptom, resulting in the dryness of the lips, tongue, pharynx, and consequently, discomfort to speak, chew and swallow dry foods. The purpose of this paper was to present a clinical case of SS, emphasizing its clinical importance and the need of an early diagnose, aiming to improve the patient’s quality of life.
Downloads
References
Abrahão JMB, Andrade ED, Groppo FC. Algumas considerações sobre a Síndrome de Sjögren. OM. 1994; 21: 25-26.
Atkinson JC, Fox PC. Sjögren´s Syndrom: Oral and dental considerations. J Am Dent Assoc. 1993; 124: 74-86.
Azevedo DT, Wajnberg MI, Saubermann LF, Geller M, Roimicher S. Síndrome de Sjögren. J Bras Med. 1971; 20:53-72.
Behrman RE, Kliegamn R, Jenson HB. Nelson: Tratado de pediatria. Rio de Janeiro: Guanabara Koogan, 2002.
Bertram U, Halberg P. Organ antibodies in Sjögren´s syndrome. Acta Allerg. 1965; 20:472-483.
Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren´s syndrome. A clinical, pathological and serological study of sixty-two cases. Medicine. 1965; 44: 187-231.
Chisholm DM, Beeley JA, Mason DK. Salivary proteins in Sjogren’s syndrome: separation by isoelectric focusing in acrylamide gels. Oral Surg Oral Med Oral Pathol. 1973; 35: 620-630.
Fox PC, Brennan M, Pillemer S, Radfar L, Yamano S, Baum BJ. Sjögren syndrom: a model for dental care in the 21st century. J Am Dent Assoc. 1998; 129: 719-28.
Fox RI, Sjögren’s syndrome: Current therapies remain inadequate for a common disease. Expert Opin Investig Drugs. 2000; 9:2007-16.
Freitas TMC, Medeiros AMC, Oliveira PT, Lima KC. Sjögren’s syndrome: literature review and clinical case management. Rev Bras Otorrinolaringol. 2004; 70:283-288.
Hamburger J. Sjögren´s Syndrome as seen by an oral physician. Scand J Rheumatol. 2001; 115:34-39.
Mandel L, Surattanont, F. Bilateral parotid swelling: A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002; 93:221-237.
Muñoz MGHCNS, Castelão WCB, Saraiva FMD, Costa JCT, Queiroz MFOV. Síndrome de Sjögren primária: manifestações exócrinas e não exócrinas. Rev Bras Reumatol. 2004; 44: 129-138.
Nakamoto RY. Use of a saliva substitute in postradiation xerostomia. J Prosthet Dent. 1979; 42:539-542.
Neville BW, Damm D, Allen M, Bouquot E. Patologia das glândulas salivares. In: Patologia Oral e Maxilofacial. Rio de Janeiro: Guanabara Koogan, 1998: 314-352.
Neville BW, Damm D, Allen M, Bouquot E. Patologia Oral e Maxilofacial. Rio de Janeiro: Guanabara Koogan, 1998.
Rauch S, Gorlin RJ. In: Gorlin RJ, Goldman HM. Thoma´s oral pathology. St. Louis: Mosby, 1970.
Simmons DD, Al-Hashimi I, Haghighat N. Effect of xerostomic medications on stimulated salivary flow rate in patients with Sjögren syndrome. Quintessence Int. 2000; 31:196-200.
Sjögren, HSC. Zur Kenntnis der Keratoconjunctivitis (Keratitis filiformis bel Hypofunktion der Tranendrüsen). Acta Ophtal. 1933: 1-151.
Sonis ST, Fazio RC, Fang L. Medicina Oral. Rio de Janeiro: Guanabara Koogan, 1985.
Sreebny LM, Broich G. Xerostomia: dry mouth. In: Sreebny L. The salivary system. Boca Raton: CRC Press, 1987.
Tommasi AF. Diagnóstico em patologia bucal. São Paulo: Pancast Editorial, 2002.
Vitali C, Bombardieri S, Jonsson R. Classification criteria for Sjögren syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis. 2002; 61: 554-558.
